An interventional study of Erector Spinae Plane Block and Intravenous fentanyl patient control device in Pain, Postoperative, sponsored by Medipol University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-07.
Sponsored by Medipol University · Not applicable, Interventional, and Treatment
Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L-shaped incision. Therefore adequate analgesia is important for recovery.
Erector Spinae Plane Block (ESPB) is a safe anesthesia technique used to provide postoperative analgesia. This study aimed to compare the novel ultrasound-guided ESPB technique with controls in terms of postoperative opioid consumption and postoperative pain control on donor patients.
5,089 studies on the registry are indexed under Pain, Postoperative; 1,137 are open to participants now.
This study's enrollment of 41 is below the median of 75 across 4,341 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Medipol University is the lead sponsor of 311 studies on the registry; 86 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Erector Spinae Plane Block for Postoperative Analgesia
Procedure: Erector Spinae Plane Block
No regional anesthesia technique will be applied to the control group.
Procedure: Intravenous fentanyl patient control device
Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.
Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.
Opioid consumption
The amount of fentanyl required by the patient and given by the device will be recorded for the first 48 hours.
Time frame: Change from baseline opioid consumption at postoperative 0, 2, 4, 6, 12, 24, 36 and 48 hours
Visual Analog Scale
Pain of patients will be evaluated and recorded according to the Visual Analog Scale.
Time frame: Change from baseline pain scores at postoperative 0, 2, 4, 6, 12, 24, 36 and 48 hours
Plan to share: No
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medipol University